Physician profile
Ryan Walsh
NPI 1295023307
$94,394.76
in general payments reported to CMS, 2019-2025
6 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $500 · 2022: $52K · 2023: $38K · 2024: $3,500.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $21K · Honoraria: $16K · Travel and Lodging: $3,595 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $750 · Food and Beverage: $283 · Gift: $139 · Education: $14.49.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $21,250.00 |
| Honoraria | $15,500.00 |
| Travel and Lodging | $3,594.72 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $750.00 |
| Food and Beverage | $283.21 |
| Gift | $138.63 |
| Education | $14.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nusmile, Ltd. | $90,266.63 | 2022-2023 | Neomta, Neoputty, Neosealer |
| Gc America INC. | $2,000.00 | 2024 | G-Aenial, Equia, G-Aenial |
| Carl Zeiss Meditec USA, INC. | $1,500.00 | 2024 | Kinevo 900 |
| Tulsa Dental Products LLC | $500.00 | 2019 | |
| Kerr Corporation | $113.64 | 2023 | K3xf |
| Septodont INC. | $14.49 | 2023 | Biodentine |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Walsh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.